Healthcare -
Drug Manufacturers - General - NYSE - US
$ 15.74
-2.72 %
$ 4.05 B
Market Cap
3.12
P/E
OGN - COST OF REVENUE
Cost of Revenue OGN - Organon & Co.
2.52 B
LAST VALUE
2.75%
2 YEAR CAGR
-11.73%
5 YEAR CAGR
0.00%
10 YEAR CAGR